STY PEPTIDES FOR INHIBITION OF ANGIOGENESIS
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Feb 9, 2017
app pub date -
Feb 25, 2015
filing date -
Feb 25, 2014
priority date (Note) -
Published
status (Latency Note)
Importance
Abstract
Peptides for the treatment of cancer and angiogenic disorders are provided. In some aspects, the peptides may be used to decrease angiogenesis or VEGF expression or function in a cancer such as, e.g., an ocular cancer. In some embodiments, a peptide of the present invention may be used to treat an angiogenic eye disorder such as, e.g., diabetic retinopathy.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully